Altimmune Inc (ALT)
$6.74
0.00 (0.00%)
ALT Stock Quote Delayed 30 Minutes
7 Small-Cap Stocks with Big Growth Potential in 2023
Some of the greatest opportunities can be found in these small-cap stocks to buy. For one, a good number of small-cap stocks are severely undervalued.…
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
477.88M
PE Ratio
-4.19
EPS
-1.61
Volume (Avg. Vol.)
460
Day's Range
-
52-Week Range
$2.09 - $14.84
Dividend & Yield
N/A (N/A)
ALT Stock Predictions, Articles, and Altimmune Inc News
ALT Stock: One Analyst Still Thinks Altimmune Prices Could Hit $34
Some clinical trial results released by Altimmune have shareholders rushing to sell. But, one analyst sees plenty of upside for ALT stock.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning! We're taking a look at the biggest pre-market stock movers for Wednesday and that includes the winners and losers.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Get ready for another busy week of trading as we kick off Monday with a look at the biggest pre-market stock movers for today.
Altimmune Earnings: ALT Stock Rises 7% Despite Rough Q2 Results
Altimmune earnings from Tuesday evening have ALT stock higher despite the company reporting rough figures for second quarter of FY2020.
Altimmune Earnings: ALT Stock Tumbles 12% on FY Miss
Altimmune (ALT) earnings for the biopharmaceutical company's fiscal year of 2019 have ALT stock taking a dive Friday after missing estimates.
Altimmune Stock Has Major Pipeline Potential
There's no guarantee of a coronavirus cure, but Altimmune stock is worth owning on hopes of an effective vaccine.
Altimmune News: ALT Stock Rockets 110% on Coronavirus Vaccine News
Altimmune (ALT) news for Monday includes positive news about a vaccine to treat the coronavirus from China have ALT stock soaring higher.
Altimmune News: ALT Stock Skyrockets on Positive Flu Vaccine Data
Altimmune news concerning the results from a Phase 2 extension study of the company's NasoVAX has ALT stock heading higher today.
Why Altimmune Stock Is Sliding Lower Today
Altimmune stock was falling hard Monday on news that the company is selling additional stock to investors in a new offering.
Why Altimmune Stock Is Skyrocketing Today
Altimmune stock (ALT) soared more than 285% following successful clinical trial data of a medication and a reverse split of common shares.
